Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2Other hematologic neoplasm 2Head & Neck 2Genitourinary 2Gastrointestinal 2Thoracic 1Sarcoma 1Plasma cell 1Other 1Lymphoid 1

Conditions

Successful Conversion Rate of Operation 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Adenocarcinoma 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Sodium Bicarbonate × Gastrointestinal × Clear all
NCT03822130 2019-02-20

Intra-arterial Infusion Chemotherapy Combined With Sodium Bicarbonate for Unresectable Gastric Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase EARLY_PHASE1 Unknown
150 enrolled
Gastrointestinal

Successful Conversion Rate of Operation

NCT01198821 2017-02-23

Gem-TABS in Unresectable Pancreatic Carcinoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
8 enrolled
Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡